MRK
Merck & Co., Inc.
NYSE · Healthcare · Drug Manufacturers - General · US
$144.27
−1.15%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$145.00
From 52W high−7.79%
Volume4.22M
Market cap$355.94B
P/E (TTM)114.5x
P/S (TTM)5.4x
Div yield2.36%
Key dataOct 19, 2026
Open
$145.00
From 52W high
−7.79%
Volume
4.22M
Market cap
$355.94B
ValuationView details →
P/E (Fwd)
16.7x
EV/EBITDA
28.9x
P/E (TTM)
114.5x
RSI (14)
49.9
MomentumView details →
1D Return
−1.15%
YTD Return
+37.71%
SummaryUpdated Jun 1, 2026
Merck & Co., Inc. (NYSE:MRK) is one of the world's largest pharmaceutical companies, founded in 1891 and headquartered in Kenilworth, New Jersey. Originally established as the American subsidiary of the German chemical company E. Merck, the company became independent during World War I and has since evolved into a global healthcare leader. Today, Merck operates as a diversified healthcare company serving patients worldwide through two primary business segments: pharmaceuticals for human health and animal health products. The company has built its reputation on developing breakthrough medicines and vaccines that address some of the most challenging diseases facing humanity.
Similar companies
Latest newsMore news →
Halper Sadeh LLC said it is investigating whether Silence Therapeutics plc and its board obtained a fair price in the company's sale to Merck & Co., Inc. for $20.00 in cash per American Depositary Share.6h agoMerck & Co., Inc. reported $18.8 billion in US revenue for Keytruda in 2025 and $22.5 billion in profits, up 16% from 2024.3d ago